PARSIPPANY, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the second quarter ended June 30, 2025 ...

Raffield provided an update that “Centerra reported yesterday that they had encountered lower-than-expected gold grades… and reduce [d] their 2025 gold production guidance to 145,000 to 165,000 ounces ...

QT Imaging Holdings, Inc. (OTCQB: QTIH) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today ...

Net interest margin (NIM) — Reported a 3.06% net interest margin for Q2 2025; management anticipates a 10 basis point ...